Aerospace Group:

Homeland Security

DoD Awards Morphotek $1.7M for Bio-defense Therapeutics

DDN

Wednesday, June 25th, 2008

SHARE:

Morphotek has received $1.7 million in funding approval from the Defense Department to further develop biologic-based monoclonal antibody (mAb) therapies targeting staphylococcal toxins as well as staph itself for the treatment of infectious diseases. Morphotek says it has developed multiple mAbs that are able to bind and neutralize the toxic effects elicited by microbial pathogens and is applying its technology to generate potent therapeutic mAbs to treat diseases caused by potential bio-warfare pathogens. Morphotek is a subsidiary of Eisai Corp.…

Congress

Trump Wants Second Reconciliation Bill On His Desk By June 1

President Donald Trump on Wednesday called on Congress to pass and send a second reconciliation bill to his desk by June 1. The deadline follows congressional Republicans’ backing a pursuit […]

Space

Upgrading Current GPS Ground System “Now a Viable Option,” As GPS OCX Problems Continue, Space Official Says

Upgrades to the GPS ground system–the Architecture Evolution Plan (AEP)–is an option under consideration by the Defense Department’s space acquisition chief, as problems continue in fielding the GPS Next Generation […]

Congress

Graham Says GOP To Move Ahead On Second Reconciliation Bill, With Defense Funds As Priority

Senate Budget Committee Chair Lindsey Graham (R-S.C.) said Wednesday, with the White House’s backing, his panel will move “expeditiously” on crafting a second reconciliation bill, citing priorities for defense and […]

Pentagon

Hegseth Acknowledges Potential $200 Billion Iran Supplemental Request, Final Figure ‘Could Move’

Defense Secretary Pete Hegseth on Thursday acknowledged the Pentagon could potentially ask Congress for $200 billion in supplemental funding to support the ongoing operation against Iran and replenish munitions used […]